Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc

Registered Charity 3104


Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

The relationship between Fibromyalgia and the MCS

Tuesday 15 December 2009

Scandinavian Journal of RheumatologyThe Scandinavian Journal of Rheumatology has published a research paper that demonstrated the links between Fibromyalgia and Multiple Chemical Sensitivity.

Although the article was first published in the Journal in 1997, we've only just discovered it. Better late than never...


Scandinavian Journal of Rheumatology

1997, Vol. 26, No. 5, Pages 364-367

The Relationship between Fibromyalgia and the Multiple Chemical Sensitivity Syndrome

A. T. Slotkoff‌1†, D. A. Radulovic‌2 and D. J. Clauw‌2

1Veteran Affairs Palo Alto Health Care System, Department of Medicine, Stanford University School of Medicine, Stanford, CA

2Division of Rheumatology, Immunology, and Allergy, Georgetown University Medical Center, Washington, DC, USA

Correspondence: A. T. Slotkoff, Building 6, Mail Code 1IC/CL, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, CA, 94304, USA

Fibromyalgia (FM) patients often report a high frequency of non-musculoskeletal symptoms, including those suggestive of multiple chemical sensitivity (MCS) syndrome. The objective of this pilot study was to determine the prevalence of MCS in FM patients from a university-based rheumatology practice. Self-report questionnaires were administered to determine the presence of MCS, utilizing the criteria from a recent study of the immunologic profile of patients with this disorder. Patients also responded “yes” or “no” to the presence of 48 FM-related symptoms. Thirty-three of 60 patients with FM met the criteria for MCS. Eleven of these patients also fulfilled more restrictive criteria, requiring a “higher degree” of chemical sensitivity. The symptoms and substances most frequently cited were similar to those reported in other studies of MCS. FM patients with and without MCS did not differ in other symptomatology. MCS may represent an additional symptom complex within the spectrum of FM.

References | PDF (425 KB) | PDF Plus (205 KB)

The above originally appeared here.


Arrow right

More Fibromyalgia News


Arrow right

More Multiple Chemical Sensitivity news



blog comments powered by Disqus

Previous Previous Page